Trial
NCT06470451
Confirmatory Study of Topical HyBryte™ vs. Placebo for the Treatment of CTCL
Phase IIITERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
Soligenix
Collaborators
—
Condition
CTCL/ Mycosis Fungoides
Intervention
Hypericin
Why stopped
The Data Monitoring Committee conducted an interim analysis and recommended that the study be halted for futility
Provenance
Dataset: 2026-07-17 • Source: ClinicalTrials.gov API v2 • Last update: 2026-07-13